Supplier log in
Agreement award for budesonide with eformoterol powder for inhalation
Details
|
Tender Closed
|
|
| RFx ID : | 25517848 |
| Tender Name : | Agreement award for budesonide with eformoterol powder for inhalation |
| Reference # : | |
| Open Date : | Wednesday, 16 March 2022 10:30 AM (Pacific/Auckland UTC+13:00) |
| Close Date : | Wednesday, 16 March 2022 10:30 AM (Pacific/Auckland UTC+13:00) |
| Tender Type : | Award Notice (AN) |
| Tender Coverage : | Sole Agency [?] |
| Categories : |
|
| Regions: |
|
| Exemption Reason : | 14.9.a Emergency |
| Required Pre-qualifications : | None |
| Contact : |
Procurement Team procurement@pharmac.govt.nz . |
| Agency Address : | |
As part of a wider decision to fund new treatments for cancer and asthma Pharmac is amending and extending the terms of agreement with AstraZeneca Pty Ltd for budesonide with eformoterol dry powder inhalers (Symbicort Turbuhaler)
You can read the full details of the decision on the Pharmac website here:
https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/2022-03-16-decision-to-fund-treatments-for-cancer-and-asthma
Pharmac published an FPO for these products in June 2021. An open market RFP was not released as it was determined that direct contracting would be suitable and necessary.
There will be protection from delisting and subsidy reduction until 31 March 2025, this means that a competitive procurement process for these products could be entered into after this date.
No Winner
As part of a wider decision to fund new treatments for cancer and asthma Pharmac is amending and extending the terms of agreement with AstraZeneca Pty Ltd for budesonide with eformoterol dry powder inhalers (Symbicort Turbuhaler)
You can read the full details of the decision on the Pharmac website here:
https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/2022-03-16-decision-to-fund-treatments-for-cancer-and-asthma
Pharmac published an FPO for these products in June 2021. An open market RFP was not released as it was determined that direct contracting would be suitable and necessary.
There will be protection from delisting and subsidy reduction until 31 March 2025, this means that a competitive procurement process for these products could be entered into after this date.
